CRRTF News and Press, Coronet Carpets Inc From 04/23/21

The following slide deck was published by Crescita Therapeutics Inc. in conjunction with this event. For further details see: Crescita Therapeutics (CRRTF) Investor Presentation - Slideshow

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company, is pleased to announce that its President and CEO, Serge Verreault will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference takin...

Crescita Announces Filing of New Medical Device License Canada NewsWire Laboratoires FILLMED files for Health Canada Approval of ART-FILLER ® Injectables in Canada LAVAL, QC , Jan. 21, 2021 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: ...

Crescita Reports Third Quarter 2020 Results PR Newswire LAVAL, QC, Nov. 12, 2020 Strong Ending Cash Balance of $13.9M LAVAL, QC , Nov. 12, 2020 /CNW Telbec/ Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Comp...

Crescita Announces Licensing Agreement for Pliaglis® in China Canada NewsWire LAVAL, QC, Nov. 5, 2020 LAVAL, QC, Nov. 5, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, inn...

Crescita Reports Second Quarter 2020 Results Canada NewsWire LAVAL, QC, Aug. 12, 2020 Strong Ending Cash Balance of $9.3M LAVAL, QC , Aug. 12, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-orie...

Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing Agreement Canada NewsWire LAVAL, QC, July 28, 2020 LAVAL, QC , July 28, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a ...

LAVAL, QC , May 14, 2020 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development ("R&D") and manufacturing c...

Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19 Canada NewsWire LAVAL, QC, April 28, 2020 LAVAL, QC , April 28, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") today announced th...

Crescita Therapeutics Announces Measures in Response to COVID-19 Virus Canada NewsWire LAVAL, QC, March 24, 2020 LAVAL, QC , March 24, 2020 /CNW/ - Crescita Therapeutics Inc. ( TSX: CTX)  ( OTC US: CRRTF ) ("Crescita" or the "Company"), a growth-oriented, inno...